fda bpc-157 compounding restrictions The scheduled a hearing on peptides and the implications could be significant for prescribers and The FDA just announced that

The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! I just testified at an FDA meeting on whether seven popular peptides should be allowed in compounding. Just last month, FDA medical officers determined that none of the peptides met the agency's I am getting so many messages there is a lot to review and a lot unfolding quickly! I want to take my time with the information and have been studying on rotations. Hopefully will get yall an only

SKU: 44270902853 · From iglepidom.org